Gene therapy and immunotherapy of prostate cancer: Adenoviral-based strategies
- 1 January 2005
- journal article
- review article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 44 (6) , 610-627
- https://doi.org/10.1080/02841860510007477
Abstract
No abstract availableKeywords
This publication has 136 references indexed in Scilit:
- A Novel TARP-Promoter-Based Adenovirus against Hormone-Dependent and Hormone-Refractory Prostate CancerMolecular Therapy, 2004
- Advances in prostate cancerCurrent Opinion in Oncology, 2004
- Identification of naturally processed CD8 T cell epitopes from prostein, a prostate tissue‐specific vaccine candidateEuropean Journal of Immunology, 2004
- Lineage relationship and protective immunity of memory CD8 T cell subsetsNature Immunology, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Transcription-targeted gene therapy for androgen-independent prostate cancerCancer Gene Therapy, 2002
- Superior Tissue-Specific Expression from Tyrosinase and Prostate-Specific Antigen Promoters/Enhancers in Helper-Dependent Compared with First-Generation Adenoviral VectorsHuman Gene Therapy, 2002
- Molecular cloning of human prostate specific antigen cDNAPublished by Wiley ,2001
- Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cellsGene Therapy, 2001
- A Novel Androgen-Regulated Gene, PMEPA1, Located on Chromosome 20q13 Exhibits High Level Expression in ProstateGenomics, 2000